Natera Inc
NTRA
Market Cap$13.32B
Close$
$97.68
8.2% downside
Current Fair Value
8.2% downsideOvervalued by 8.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.32 Billion |
|---|---|
| Enterprise Value | $12.81 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.78 |
| Beta | 1.27 |
| Outstanding Shares | 122,802,694 |
| Avg 30 Day Volume | 1,336,812 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -30.64 |
|---|---|
| PEG | 67.69 |
| Price to Sales | 13.31 |
| Price to Book Ratio | 17.74 |
| Enterprise Value to Revenue | 11.83 |
| Enterprise Value to EBIT | -28.7 |
| Enterprise Value to Net Income | -30 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
ESG Score
No data
About Natera Inc
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...